The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Volchenko N.N.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Burakova V.A.

N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia

Surkova V.S.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Sannikova V.S.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Borisova O.V.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Rare thyroid carcinomas

Authors:

Volchenko N.N., Burakova V.A., Surkova V.S., Sannikova V.S., Borisova O.V.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2023;12(3): 70‑75

DOI: 10.17116/onkolog20231203170

Views: 1819

Downloaded: 32

Download PDF (RU)
Contact the author
Table of contents

RARE THYROID CARCINOMAS
RARE THYROID CARCINOMAS

To cite this article:

Volchenko NN, Burakova VA, Surkova VS, Sannikova VS, Borisova OV. Rare thyroid carcinomas. P.A. Herzen Journal of Oncology. 2023;12(3):70‑75. (In Russ.)
https://doi.org/10.17116/onkolog20231203170

Подписка 2025-2 (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Close metadata
Recommended articles:
Meta­static lesion of lymph nodes in papi­llary thyroid cancer on the background of autoimmune thyroiditis. P.A. Herzen Journal of Onco­logy. 2024;(3):27-33
Effi­cacy of prevention of recu­rrent lary­ngeal nerve injury in thyroid surgery. Piro­gov Russian Journal of Surgery. 2024;(7):85-91
Complications and technical aspe­cts of safe tissue dissection in endo­scopic hemi­thyroidectomy. Piro­gov Russian Journal of Surgery. 2024;(9):66-74
Prediction of papi­llary thyroid cancer recu­rrence acco­rding to preoperative data. Piro­gov Russian Journal of Surgery. 2024;(9):76-85
High-grade enca­psulated follicular cell thyroid carcinomas. Russian Journal of Archive of Pathology. 2024;(5):60-64
A case of sporadic medu­llary cancer in an elde­rly patient with multinodular toxic goitre. Russian Journal of Preventive Medi­cine. 2024;(12):140-144
Nutrition, inte­stinal microbiota, and thyroid autoimmune pathology. Russian Journal of Preventive Medi­cine. 2025;(1):102-108
Prevention of recu­rrent lary­ngeal nerve injury in thyroid surgery: a systematic review and meta-analysis. Piro­gov Russian Journal of Surgery. 2025;(3):140-148

Clinical cases of rare thyroid carcinomas, morphologically similar to tumors of the mammary and salivary glands, are practically not found in the literature. To date, about 15 cases of secretory carcinoma and about 50 cases of sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland have been described. The frequency of detection of these tumors and the scarcity of available clinical and morphological data allow to combine them into a group of rare nosologies. This article presents two clinical cases: secretory carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland.

Keywords:

secretory carcinoma
sclerosing mucoepidermoid carcinoma with eosinophilia
mucoepidermoid carcinoma
thyroid
ETV6-NTRK3 gene fusion
Hashimoto’s thyroiditis
ultimobranchial cells

Authors:

Volchenko N.N.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Burakova V.A.

N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia

Surkova V.S.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Sannikova V.S.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Borisova O.V.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Received:

20.05.2022

Accepted:

22.06.2022

List of references:

  1. Baloch ZW, LiVolsi VA. Special types of thyroid carcinoma. Histopathology. 2018;72(1):40-52.  https://doi.org/10.1111/his.13348
  2. Huang NS, Cao YM, Lu ZW, Guan Q, Chen JY, Ma B, Chen TZ, Bai QM, Wang YL, Ji QH. Mammary analog secretory carcinoma of the thyroid gland: a rare cancer harboring TRK fusion. Oral Oncol. 2021;115:105092. https://doi.org/10.1016/j.oraloncology.2020.105092
  3. Reynolds S, Shaheen M, Olson G, Barry M, Wu J, Bocklage T. A case of primary mammary analog secretory carcinoma (MASC) of the thyroid masquerading as papillary thyroid carcinoma: potentially more than a one off. Head Neck Pathol. 2016;10(3):405-413.  https://doi.org/10.1007/s12105-016-0715-8
  4. Dettloff J, Seethala RR, Stevens TM, Brandwein-Gensler M, Centeno BA, Otto K, et al. Mammary analog secretory carcinoma (MASC) involving the thyroid gland: a report of the first 3 cases. Head Neck Pathol. 2017;11(2):124-130.  https://doi.org/10.1007/s12105-016-0741-6
  5. Iftikhar H, Awan MS, Ghaloo SK, Fatima S. Sclerosing mucoepidermoid carcinoma with eosinophilia of thyroid. BMJ Case Rep. 2019;12(8):e225685. https://doi.org/10.1136/bcr-2018-225685
  6. Rhatigan RM, Roque JL, Bucher RL. Mucoepidermoid carcinoma of the thyroid gland. Cancer. 1977;39(1):210-214.  https://doi.org/10.1002/1097-0142(197701)39:1<210::aid-cncr2820390133>3.0.co;2-h
  7. Sim SJ, Ro JY, Ordonez NG, Cleary KR, Ayala AG. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: report of two patients, one with distant metastasis, and review of the literature. Hum Pathol. 1997;28(9):1091-1096. https://doi.org/10.1016/s0046-8177(97)90064-2
  8. Chan JK, Albores-Saavedra J, Battifora H, Carcangiu ML, Rosai J. Sclerosing mucoepidermoid thyroid carcinoma with eosinophilia. A distinctive low-grade malignancy arising from the metaplastic follicles of Hashimoto’s thyroiditis. Am J Surg Pathol. 1991;15(5):438-448. 
  9. Raveendran Nair AKA, George NA, Kumar R, Sreekumar A, Jayasree K. Sclerosing mucoepidermoid carcinoma with eosinophilia of thyroid gland: not so indolent a neoplasm? Indian J Pathol Microbiol. 2018;61(2):242-244.  https://doi.org/10.4103/IJPM.IJPM_169_17
  10. Salem J, Shamil E, Ffolkes L, Ofo E. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: demonstrating the natural progression of a rare and misunderstood disease. BMJ Case Rep. 2021;14(7):e241086. https://doi.org/10.1136/bcr-2020-241086
  11. Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simões M, Tallini G, et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol. 2022;33(1):27-63.  https://doi.org/10.1007/s12022-022-09707-3
  12. Quiroga-Garza G, Lee JH, El-Naggar A, Black JO, Amrikachi M, Zhai QJ, Ayala AG, Ro JY. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: more aggressive than previously reported. Hum Pathol. 2015;46(5):725-731.  https://doi.org/10.1016/j.humpath.2015.01.012
  13. Ríos Moreno MJ, Galera-Ruiz H, De Miguel M, López MI, Illanes M, Galera-Davidson H. Inmunohistochemical profile of solid cell nest of thyroid gland. Endocr Pathol. 2011;22(1):35-39.  https://doi.org/10.1007/s12022-010-9145-4
  14. Sukumar JS, Sukumar S, Purohit D, Welch BJ, Balani J, Yan S, Hathiramani SS. Activating BRAF mutation in sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: two case reports and review of the literature. J Med Case Rep. 2019;13(1):385.  https://doi.org/10.1186/s13256-019-2288-0
  15. Chambers M, Nosé V, Sadow PM, Tafe LJ, Kerr DA. Salivary-like tumors of the thyroid: a comprehensive review of three rare carcinomas. Head Neck Pathol. 2021;15(1):212-224.  https://doi.org/10.1007/s12105-020-01193-5
  16. Le HT, Nguyen TPX, Hirokawa M, Katoh R, Mitsutake N, Matsuse M, Sako A, Kondo T, Vasan N, Kim YM, et al. Primary thyroid mucoepidermoid carcinoma (MEC) is clinically, prognostically, and molecularly different from sclerosing MEC with eosinophilia: a multicenter and integrated study. Endocr Pathol. 2023;34(1):100-111.  https://doi.org/10.1007/s12022-022-09741-1
  17. Prichard RS, Lee JC, Gill AJ, Sywak MS, Fingleton L, Robinson BG, Sidhu SB, Delbridge LW. Mucoepidermoid carcinoma of the thyroid: a report of three cases and postulated histogenesis. Thyroid. 2012;22(2):205-209.  https://doi.org/10.1089/thy.2011.0276
  18. Yan W, Chen H, Li J, Zhou R, Su J. Primary squamous cell carcinoma of thyroid gland: 11 case reports and a population-based study. World J Surg Oncol. 2022;20(1):352.  https://doi.org/10.1186/s12957-022-02814-9
  19. Solomon AC, Baloch ZW, Salhany KE, Mandel S, Weber RS, LiVolsi VA. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia: mimic of Hodgkin disease in nodal metastases. Arch Pathol Lab Med. 2000;124(3):446-449.  https://doi.org/10.5858/2000-124-0446-TSMCWE
  20. Pantola C, Kala S, Athar M, Thakur S. Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: a cytological dilemma. J Cytol. 2016;33(1):37-39.  https://doi.org/10.4103/0970-9371.175511
  21. Noor M, Russell DK, Israel AK, Lott Limbach A. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia in conjunction with parotid basal cell adenoma: cytologic, histologic, and molecular features. Diagn Cytopathol. 2021;49(7):262-268.  https://doi.org/10.1002/dc.24701
  22. Ames E, Campbell MJ, Afify A, Krane JF, Huang EC. Sclerosing mucoepidermoid carcinoma with eosinophilia: cytologic characterization of a rare distinct entity in the thyroid. Diagn Cytopathol. 2018;46(7):632-635.  https://doi.org/10.1002/dc.23914
  23. Rupp AP, Bocklage TJ. Mammary analog secretory carcinoma of thyroid: a case report. Diagn Cytopathol. 2017;45(1):45-50.  https://doi.org/10.1002/dc.23608
  24. Baloch ZW, Segal JP, Livolsi VA. Unique growth pattern in papillary carcinoma of the thyroid gland mimicking adenoid cystic carcinoma. Endocr Pathol. 2011;22(4):200-205.  https://doi.org/10.1007/s12022-011-9174-7
  25. Levy GH, Marti JL, Cai G, Kayne RD, Udelsman R, Hammers LW, Kowalski DP, Prasad ML. Pleomorphic adenoma arising in an incidental midline isthmic thyroid nodule: a case report and review of the literature. Hum Pathol. 2012;43(1):134-137.  https://doi.org/10.1016/j.humpath.2011.02.025
  26. Leeman-Neill RJ, Kelly LM, Liu P, Brenner AV, Little MP, Bogdanova TI, Evdokimova VN, Hatch M, Zurnadzy LY, Nikiforova MN, et al. ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer. 2014;120(6):799-807.  https://doi.org/10.1002/cncr.28484
  27. Santoro M, Carlomagno F. Oncogenic rearrangements driving ionizing radiation-associated human cancer. J Clin Invest. 2013;123(11):4566-4568. https://doi.org/10.1172/JCI72725
  28. Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, et al. Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med. 2018;378(8):731-739.  https://doi.org/10.1056/NEJMoa1714448
  29. Drilon A, Nagasubramanian R, Blake JF, Ku N, Tuch BB, Ebata K, Smith S, Lauriault V, Kolakowski GR, Brandhuber BJ, et al. A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion-positive solid tumors. Cancer Discov. 2017;7(9):963-972.  https://doi.org/10.1158/2159-8290.CD-17-0507

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.